Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Human hair follicles have a scent receptor that can influence hair growth.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Alopecia areata treatment varies, with no optimal method established yet.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Dupilumab helps children with alopecia areata regrow hair safely.

Recent advances in hair loss treatments show significant progress.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Ruxolitinib treatment may cause eyelash growth.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

miRNAs could help diagnose and treat gouty arthritis.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.